Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹140 Cr
Revenue (TTM)
₹39 Cr
Net Profit (TTM)
₹-5 Cr
ROE
-42.6 %
ROCE
-0.5 %
P/E Ratio
--
P/B Ratio
-32.5
Industry P/E
--
EV/EBITDA
116.7
Div. Yield
-- %
Debt to Equity
6.7
Book Value
₹3.4
EPS
₹-2.5
Face value
10
Shares outstanding
19,244,500
CFO
-0.89 Cr
EBITDA
15.93 Cr
Net Profit
-5.59 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
No Review & Analysis are available.
--
Incorporated
1993
Chairman
K R V Subrahmanian
Managing Director
R Sundara Rajan
Headquarters
Chennai, Tamil Nadu
Website
--
Annual Reports
Since, TTM earnings of Medicorp Technologies India Ltd [Merged] is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2002
|
0.00
|
2.38
|
|
2001
|
0.00
|
2.00
|
|
2000
|
12.83
|
1.78
|
|
1999
|
40.73
|
3.28
|
|
1998
|
0.00
|
0.00
|
The 52-week high and low of Medicorp Technologies India Ltd [Merged] are Rs -- and Rs -- as of 05-Apr-2026.
Medicorp Technologies India Ltd [Merged] has a market capitalisation of ₹ 140 Cr as on 16-Jun-2003. As per SEBI classification, it is a company.
Before investing in Medicorp Technologies India Ltd [Merged], assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.